Suvorexant drug may offer new approach to treating insomnia

November 28, 2012

A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

The drug, suvorexant, blocks the in the brain called orexins, which regulate . Other drugs for insomnia affect different .

Taking the drug suvorexant increased the amount of time people spent asleep during the night, according to the study. The study involved 254 people ages 18 to 64 who were in good physical and mental health but had insomnia that was not due to another .

The participants took either the drug or a placebo for four weeks, then switched to the other treatment for another four weeks. The participants spent the night in a sleep laboratory with their sleep monitored on the first night with each treatment and then again in the fourth week of each treatment.

While taking the drug, participants' "sleep efficiency," which reflects the total amount of time they slept during a fixed, eight hour time in bed, improved by 5 to 13 percent compared to those taking the placebo. They also experienced 21 to 37 fewer minutes awake during the night after they had fallen asleep than those who took the placebo.

"This study provides evidence that suvorexant may offer a successful alternative strategy for treating insomnia," said study author W. Joseph Herring, MD, PhD, of North Wales, Penn., Executive Director of with Merck, the maker of suvorexant, and a member of the American Academy of Neurology. "Suvorexant was generally well-tolerated, and there were no serious side effects."

Herring said larger, longer studies have recently been conducted on suvorexant, along with studies to determine whether the drug could be safe and effective for elderly people, who make up a large percentage of those suffering from .

Explore further: FDA reviewing Merck's experimental insomnia drug

Related Stories

Making headway on beta-blockers and sleep

September 28, 2012

Over 20 million people in the United States take beta-blockers, a medication commonly prescribed for cardiovascular issues, anxiety, hypertension and more. Many of these same people also have trouble sleeping, a side effect ...

Study: Insomnia linked to hypertension

June 6, 2012

People with insomnia may now have one more thing to keep them up at night: an increased likelihood of developing hypertension, according to a study from Henry Ford Hospital in Detroit.

Recommended for you

Scientists track unexpected mechanisms of memory

September 29, 2016

Do you remember Simone Biles's epic gymnastics floor routine that earned her a fifth Olympic medal? Our brains hold on to memories like these via physical changes in synapses, the tiny connections between neurons.

Brain's biological clock stimulates thirst before sleep

September 28, 2016

The brain's biological clock stimulates thirst in the hours before sleep, according to a study published in the journal Nature by researchers from the Research Institute of the McGill University Health Centre (RI-MUHC).

Some brains are blind to moving objects

September 28, 2016

As many as half of people are blind to motion in some part of their field of vision, but the deficit doesn't have anything to do with the eyes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.